<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Whillock AL</submitter><funding>U.S. Department of Health &amp;amp;amp; Human Services | National Institutes of Health</funding><funding>BLRD VA</funding><funding>NIEHS NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>Center for Integrated Healthcare, U.S. Department of Veterans Affairs</funding><pagination>12884</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6733949</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>TRAF3 is a versatile intracellular adapter protein with multiple context-specific roles. Uniquely in B cells, TRAF3 deficiency enhances survival and increases the risk of transformation, as loss of TRAF3 is observed in several types of B cell cancers. Here, we report a new mechanism for TRAF3 in the restraint of B cell survival. We found that TRAF3 deficiency was associated with induction of the pro-survival kinase Pim2 in mouse primary B cells and human malignant B cell lines. The increase in Pim2 was independent of NF-κB2 activation but was ameliorated with inhibition of STAT3 expression or function. TRAF3 deficiency also led to a Pim2-dependent increase in c-Myc protein levels and was associated with reduced c-Myc ubiquitination. TRAF3-deficient primary B cells were less sensitive to ce</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells.</pubmed_title><pmcid>PMC6733949</pmcid><funding_grant_id>T32 AI07485</funding_grant_id><funding_grant_id>P30 ES005605</funding_grant_id><funding_grant_id>P30 CA086862</funding_grant_id><funding_grant_id>T32 AI007485</funding_grant_id><funding_grant_id>I01 BX001702</funding_grant_id><funding_grant_id>T32 GM007337</funding_grant_id><funding_grant_id>T32 AI007533</funding_grant_id><funding_grant_id>MR I01 BS001702</funding_grant_id><funding_grant_id>P50 CA097274</funding_grant_id><funding_grant_id>P50 CA97274</funding_grant_id><pubmed_authors>Stunz LL</pubmed_authors><pubmed_authors>Whillock AL</pubmed_authors><pubmed_authors>Lin WW</pubmed_authors><pubmed_authors>Mambetsariev N</pubmed_authors><pubmed_authors>Bishop GA</pubmed_authors></additional><is_claimable>false</is_claimable><name>TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells.</name><description>TRAF3 is a versatile intracellular adapter protein with multiple context-specific roles. Uniquely in B cells, TRAF3 deficiency enhances survival and increases the risk of transformation, as loss of TRAF3 is observed in several types of B cell cancers. Here, we report a new mechanism for TRAF3 in the restraint of B cell survival. We found that TRAF3 deficiency was associated with induction of the pro-survival kinase Pim2 in mouse primary B cells and human malignant B cell lines. The increase in Pim2 was independent of NF-κB2 activation but was ameliorated with inhibition of STAT3 expression or function. TRAF3 deficiency also led to a Pim2-dependent increase in c-Myc protein levels and was associated with reduced c-Myc ubiquitination. TRAF3-deficient primary B cells were less sensitive to ce</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2025-04-21T23:22:11.701Z</modification><creation>2020-05-21T18:59:38Z</creation></dates><accession>S-EPMC6733949</accession><cross_references><pubmed>31501481</pubmed><doi>10.1038/s41598-019-49390-9</doi></cross_references></HashMap>